HER2-positive breast cancer is a subtype of breast cancer, which is associated with high invasiveness, high risk of recurrence, rapid progression, and poor prognosis and is an independent factor in poor prognosis of breast cancer patients (9–12). This evidence concerns the gene ERBB2 and breast carcinoma.